Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Total Debt (2020 - 2025)

Historic Total Debt for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $51.6 million.

  • GeneDx Holdings' Total Debt fell 87.44% to $51.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.6 million, marking a year-over-year decrease of 87.44%. This contributed to the annual value of $51.9 million for FY2024, which is 147.09% down from last year.
  • Per GeneDx Holdings' latest filing, its Total Debt stood at $51.6 million for Q3 2025, which was down 87.44% from $51.7 million recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Total Debt ranged from a high of $52.7 million in Q4 2023 and a low of $6.1 million during Q3 2023
  • In the last 5 years, GeneDx Holdings' Total Debt had a median value of $19.3 million in 2021 and averaged $29.1 million.
  • Per our database at Business Quant, GeneDx Holdings' Total Debt plummeted by 5319.75% in 2023 and then surged by 75978.19% in 2024.
  • Over the past 5 years, GeneDx Holdings' Total Debt (Quarter) stood at $13.6 million in 2021, then dropped by 27.75% to $9.8 million in 2022, then surged by 435.28% to $52.7 million in 2023, then decreased by 1.47% to $51.9 million in 2024, then fell by 0.64% to $51.6 million in 2025.
  • Its last three reported values are $51.6 million in Q3 2025, $51.7 million for Q2 2025, and $51.8 million during Q1 2025.